Marksans Pharma Limited (MARKSANS) Share Analysis
NSE · Healthcare · Pharmaceuticals
Marksans Pharma Limited (NSE: MARKSANS) is an Indian listed company in the Pharmaceuticals sector and a constituent of NIFTY Microcap 250. As of 21 Sep 2026, the share price was ₹320.00, market capitalisation ₹14,508 Cr, P/E 28.1, ROE 15.2%.
Get the AI verdict on MARKSANS: BUY, BUY ON DIPS, WAIT or EXIT
Sign in for the full analysis — AI fundamental and technical analysis, recent news, and one verdict with an entry zone, two targets and a stop-loss, for a 3-month, 1-year, 3-year or 5-year horizon. A free plan is available.
Stored fundamentals as of 21 Sep 2026 — not a live quote. Signed-in analysis uses same-day data.
MARKSANS price and valuation
- Share price
- ₹320.00
- Market cap
- ₹14,508 Cr
- P/E ratio
- 28.1
- P/B ratio
- 4.8
- EPS
- ₹11.41
- Book value per share
- ₹66.70
- Dividend yield
- 0.28%
MARKSANS profitability and growth
- ROE
- 15.2%
- ROCE
- 18.8%
- Debt to equity
- 0.11
- Revenue growth (3 yr)
- 17%
- Revenue growth (5 yr)
- 16%
- Profit growth (3 yr)
- 16%
- Profit growth (5 yr)
- 12%
MARKSANS 52-week range
- 52-week high
- ₹349.95
- 52-week low
- ₹155.00
- Face value
- ₹1.00
MARKSANS shareholding pattern
- Promoters
- 43.87%
- FIIs
- 17.47%
- DIIs
- 6.19%
- Public
- 32.46%
Index membership: NIFTY Microcap 250.
Learn to read these numbers
- Metrics glossary — what P/E, ROE, ROCE and debt-to-equity mean.
- Investment Blogs — free lessons on fundamental and technical analysis.
- AI stock picks and Discover stocks by sector and index.
- How Stock-Analyze works — what the AI analysis and verdict cover.